WHO CC for Training and Policy on Access to Pain Relief, India
Side Event - International Doctors for Healthier Drug Policies
Commission on Narcotics Drugs, UN, Vienna
National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.
National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.
Join Bill Dempster & guests Louise Binder & Martine Elias as they discuss the updates to the federal pharmaceutical price reform proposal, how patient leaders are responding and what steps they are taking to ensure that patients are being heard by decision makers.
“Intervention of a clinical pharmacist in order to reduce polypharmacy, avera...SriramNagarajan17
“Intervention of a clinical pharmacist in order to reduce polypharmacy, average cost of therapy and percentage of patients received injections (parenterals) in pediatrics dept; study carried out at multi-specialty teaching hospital”
Global Healthcare Marketing is evolving as emerging markets quickly mature. Clinical standards, payer structures and marketing messages are a combination of variables to be accounted for in unlocking market access challenges.
www.healthcaremedicalpharmaceuticaldirectory.com - a healthcare industry resource
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
Global healthcare marketing strategies and tactics are being re-positioned as emerging markets mature, access to care increases and clinical / payer administration becomes more established.
China, Brazil, India, Saudi Arabia
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
At the Partnership for Safe Medicines 2011 Interchange conference, Xuanhao Chan from the Int'l. Pharmaceutical Federation talked about the challenges in combating counterfeit medicines today.
Pain points - Overcoming the Opioid CrisisCompleteRx
Today, 11 percent of Americans experience daily chronic pain, for which opioids are frequently prescribed. Unfortunately, what started as standard prescribing practice has become detrimental, and due to their highly addictive nature, we’ve seen a quadrupling number of opioid overdose deaths from 1999 to 2015, killing more than 90 people per day. While state and national legislatures continue to search for ways to combat this epidemic, significant change can be made at the community level starting with medical staff, hospitals and health systems. This webinar will provide a comprehensive overview of the pain crisis and how it affects various patient populations, outline CDC guidelines on opioid use for chronic pain and identify strategies to positively impact the use of opioids and outcomes.
Sources: NCCIH, NPR
Key Takeaways:
- Recognize the relationship between opioid use on clinical and economic outcomes in various patient populations and the community
- Outline recommendations suggested by CDC guidelines on opioid use in chronic pain and new pain standards just released by TJC
- Identify strategies to impact multiple drivers of the opioid crisis
Join Bill Dempster & guests Louise Binder & Martine Elias as they discuss the updates to the federal pharmaceutical price reform proposal, how patient leaders are responding and what steps they are taking to ensure that patients are being heard by decision makers.
“Intervention of a clinical pharmacist in order to reduce polypharmacy, avera...SriramNagarajan17
“Intervention of a clinical pharmacist in order to reduce polypharmacy, average cost of therapy and percentage of patients received injections (parenterals) in pediatrics dept; study carried out at multi-specialty teaching hospital”
Global Healthcare Marketing is evolving as emerging markets quickly mature. Clinical standards, payer structures and marketing messages are a combination of variables to be accounted for in unlocking market access challenges.
www.healthcaremedicalpharmaceuticaldirectory.com - a healthcare industry resource
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
Global healthcare marketing strategies and tactics are being re-positioned as emerging markets mature, access to care increases and clinical / payer administration becomes more established.
China, Brazil, India, Saudi Arabia
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
At the Partnership for Safe Medicines 2011 Interchange conference, Xuanhao Chan from the Int'l. Pharmaceutical Federation talked about the challenges in combating counterfeit medicines today.
Pain points - Overcoming the Opioid CrisisCompleteRx
Today, 11 percent of Americans experience daily chronic pain, for which opioids are frequently prescribed. Unfortunately, what started as standard prescribing practice has become detrimental, and due to their highly addictive nature, we’ve seen a quadrupling number of opioid overdose deaths from 1999 to 2015, killing more than 90 people per day. While state and national legislatures continue to search for ways to combat this epidemic, significant change can be made at the community level starting with medical staff, hospitals and health systems. This webinar will provide a comprehensive overview of the pain crisis and how it affects various patient populations, outline CDC guidelines on opioid use for chronic pain and identify strategies to positively impact the use of opioids and outcomes.
Sources: NCCIH, NPR
Key Takeaways:
- Recognize the relationship between opioid use on clinical and economic outcomes in various patient populations and the community
- Outline recommendations suggested by CDC guidelines on opioid use in chronic pain and new pain standards just released by TJC
- Identify strategies to impact multiple drivers of the opioid crisis
This presentation was Oladimeji Oladepo of the University of Ibadan at a Future Health Systems conference in Abuja, Nigeria, in January 2009. www.futurehealthsystems.org.
An Essential Drug List, also known as a core drug list or medication list, is a carefully selected inventory of medications that are deemed essential for addressing the most prevalent health conditions within a specific population or country. It serves as a key component of national drug policies and pharmaceutical programs, ensuring the availability, accessibility, and affordability of essential medicines. The list is typically developed based on rigorous criteria, taking into consideration the medications' safety, efficacy, cost-effectiveness, and suitability for primary healthcare settings.
Rational Drug Therapy refers to the systematic and evidence-based approach to prescribing medications, aiming to maximize therapeutic benefits while minimizing the risk of adverse effects. It involves following established therapeutic guidelines and clinical protocols to ensure that medications are prescribed in a manner that is appropriate for the patient's condition, taking into account factors such as age, weight, co-existing conditions, drug interactions, and individual response. Rational drug therapy promotes the use of medications based on sound scientific evidence, emphasizing the principles of efficacy, safety, and cost-effectiveness to optimize patient outcomes and improve overall healthcare quality.
80% of the world’s population is denied access to morphine – while 20% consume almost all of it.
It is hard to think of a greater injustice that has largely arisen from the misunderstanding and fear of international drug policy
This is why IDHDP launched its campaign “Striving for equity in the treatment of pain.”
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxglendar3
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
Drug Treatment Systems in Russian Hospitals and Prisons: Inefficient and lack...IDHDP
Drug Treatment Systems in Russian Hospitals and Prisons: Inefficient and lacking in evidence
Prof. Vladimir Mendelevich, MD, PhD
Kazan State Medical University
Russian Federation
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Nandini vallathvienna final
1. Striving for equity in
the treatment of pain
Nandini Vallath
WHO CC for Training and Policy on Access to Pain Relief, India
Side Event - International Doctors for Healthier Drug Policies
Commission on Narcotics Drugs, UN, Vienna
2. Pain management requires Opioid
medications
WHO Model List of
Essential Medicines
Zech DF et al - Validation of World Health Organization
Guidelines for cancer pain relief: a 10-year prospective
study. Pain. 1995.63(1):65-76.
6. • 96% adults and 99% children who require opioids DO
NOT have access to it
Unbearable Pain ….Human Rights Watch report – 2010
Duthey B, Scholten W: J of Pain and Symptom management 2013
http://www.nacoonline.org/QuickLinks/HIVData
1/6th of world’s population
7. Inequity in the treatment of pain
Does drug policy have a role?
8. Inequity in the treatment of pain
• India a major producer
• Regulatory obstacles became
obvious in the 1990s
• Doctors Taxation
department
9. Central Bureau of Narcotics
Ministry of Finance
National Competent Authority
10. 18th -19th century
Opium as trade crop
• Need for monopoly
dictated the policy
language
19th -20th century
Opioids as drug for abuse
• Need to eradicate drug
abuse dictated the
policy language
11. Medical use
NOT within
policy
language
Poor stocking
Under-treatment
Fear
Poor demand
Prohibitory orientation of policies
impacted Knowledge, Attitudes,
Priorities and AVAILABILITY
Lack of Job
mandate for
NCA
for ensuring
availability
Complex
procurement,
procedures,
prescriptions
Doctors
No Training,
Experience in
using Opioids
Misconceptions
about opioid
benefits / risks
Threat of
Harsh
punishments
12. International Narcotics Control Board
Central Bureau of Narcotics
Ministry of Finance
Production
at Govt. Factories
Quotas to
Manufacturers
Opioid
Consumption
Mandate for
Regulations
Pain Relief Providers
Narcotics Control Bureau
Ministry of Home Affairs
Enforcement of drug laws
Distribution System
in India
1231-03-2016
Availability of essential
narcotics is NOT a
mandate at any of NCA
office!!
13. Post NDPS Act 1985, Morphine
consumption in india ↓ by 97% [716 Kg 18 Kgs]
Dr Nandini Vallath 13
14. J Cleary et al Annals of Oncology - Vol 24 (11) Dec 2013
15. Basis for National Drug Policies
• Ensure availability of drugs for medical and scientific
use
• “the medical use of narcotic drugs continues to be
indispensable for the relief of pain and suffering…
adequate provision must be made to ensure the availability
of narcotic drugs for such purposes.” Preamble, p. 13
• Prevent against diversion and abuse
• “addiction to narcotic drugs constitutes a serious evil for the
individual and is fraught with social and economic danger
to mankind…” Preamble, p. 13
16. 18th -19th century
Opium as trade crop
• Need for monopoly
dictated the policy
language
19th -20th century
Opioids as drug for abuse
• Need to eradicate drug
abuse dictated the
policy language
20th -21st century
Opioids as medicine
• Need to improve access
for medical use to
dictate policy language
19. What did it take for policy reform in India?
• Acknowledging Untreated pain as a major public health issue
• Awareness of the contribution of policy language to availability
• 25 years of efforts
• Support ……lots and lots of it
24. 2014 Amendment of NDPS Act
Transformation of mindset of key policy makers - the notion that
ensuring opioid availability is an essential objective of the national
narcotic control policy
25.
26. March 2016 - India
• The Revised Rules following the 2014 Act amendment not released
• Old barriers with New look
27. Unmet need for pain relief Continues
Study at Cancer Centres: Kolkata, Hyderabad, Ahmedabad, Cuttack
79.7% of the patients who came in with pain received inadequate or NO
pain management
30%
Authors: M R Rajagopal, Gayatri Palat, Joseph Amon, Diederik Lohman
28. Quality of Death Index
Wide availability of opioid analgesics-
was a constant element in countries
with high Indices
India
Ref: Economist Intelligence Report
30. What if all member states have
policies with appropriate
language ……??
Ensured and SAFE
access and
availability of
essential drugs
Poor access and
availability of
essential drugs
?
31. Striving for equity in the treatment
of pain
•Yes, we should have supportive drug policy
•What more should we do to overcome the
inequity?
33. Process towards equity
• Changing the perception of the purpose of drug policy
• Culture and mandates of competent authorities
• Reflect the spirit of policy reform in the functioning units
• Interagency collaboration, Participatory, inclusive consultative
processes
34. Perception of Purpose at the Highest level
Illicit use medical use
In the 5 UN Drug reports
……Out of the total
256 times of
mentioning “opioids”
"opioids for medical use” is mentioned 9 times
HRW
36. Perception Purpose at the NCA
Revenue, Finance, Police, Crime, Home,
Foreign affairs, Economic development,
Drug enforcement, internal affairs
DEPARTMENT OF HEALTH
37. Reorientation of Policy Mandate
The Convention to articulate specific
provisions to ensure availability
Reorient National Drug Policy
Identify negative language, themes Add
Specific strategies, action plans
National Competent Authority
Should have Opioid Availability as their job mandate
38. Process towards equity
• Changing the perception of purpose of drug policy
• Culture and mandates of competent authorities
• Reflect the spirit of policy reform in the functions
• Interagency collaboration, Participatory, inclusive consultative
processes
39. Review of Policy Tools
Intent, priorities, language of the National Drug Control Strategy
With Specific Provisions and plans towards balance
41. Process towards equity
• Changing the perception of purpose of drug policy
• Culture and mandates of competent authorities
• Reflect the spirit of policy reform in the functions of the competent
authorities
• Interagency cooperation and collaborative action
• Participatory Inclusive consultative processes
42. Resources
• WHO guidelines for Ensuring balance in national policies
• WHO, UNODC and UNAIDS Technical Guides
• WHO/INCB Guidance for estimates
• World Health Assembly Resolution on Palliative Care
• International Community as Regional consultative Bodies?
43. Strong Licit Drug Distribution System
Level 6. PATIENTS
Level 2: National Competent Authority
Level 3. Importer/Manufacturers/Distributors
Level 1: International Narcotics Control Board
Level 4. Hospitals/Pharmacies/Hospice/PC
programs
Level 5. Physicians/Pharmacists/Other
X
45. Agencies of
the UN unite
Conventions
Clear
Purpose of
drug policy
Medical
Availability a Job
Mandate of NCA
Functioning
supply and
distribution
systems
Simple
procedures for
access
Knowledge in
SAFE medical
usage of
opioids
Penalties
proportionate
to offence
46. More and more of Justice …..less and less of Rules
International
Community
NCA
They combined INCB 2013 data with epidemiological factors that influence the regional medical need for opioid analgesics
> 80 % global population live in countries that utilise 9.5% of world’s licit opium
Focus of national regulations is prohibitory Negative language
“Medical Use” and the patient requiring these medicines left undefined within the policy
Multiple licenses and agencies causing barriers for transportation from source to dispensary
Inadequate knowledge - Concerns about addiction, negative attitudes, rreluctance to prescribe or stock
Special authorization required to prescribe special forms to fill
Discouraged by the extra administrative, record keeping requirements
Anxiety of harsh punishments for even minor errors
Misconceptions and opiophobia- professionals, public and POLICY MAKERS
Poor availability of palliative care and pain management services
Government opium and Alkaloid Works
Of the many contributory factors – prescription related factors are mentioned here
E.G India - Restrictions on the drug and quantity and duration that may be prescribed – e.g. Methadone may be prescribed for OST but not for pain management
Opioids belong to the Schedule 1.
Because of this, opioid production, consumption, and importation are strictly controlled
Time changes perspectives
Striving for improving access to pain relief
The experience from India of engaging with policy makers, judicial interventions and advocacy, awareness activity
25 years of relentless efforts
Evolution of a diligent multi-sectorial civil-society alliance committed to reform
Wonderful citizens of India
Cancer Control Policy prioritized availability of opioids
Awareness workshops – 1992-1994
Direct Supply – 10,000 tablets purchased by Min of Health for the Cancer centres
Licensure difficulties with distribution
Refusal to accept the consignment, misconceptions on opioids
Dialogue between the Department of Revenue Min of Health
Transitions in job mandates unclear
Implementation strategies not clearly defined
There is an entrenched anti-drug culture
Debate on Standard Operating procedures
2015 Index evaluates 80 countries using 20 quantitative and qualitative indicators across five categories: the palliative and healthcare environment, human resources, the affordability of care, the quality of care and the level of community engagement
> 70 % countries had unsatisfactory QOL during terminal phase
Some amongst the reds and orange do have policy language
Law enforcement
Perceptions and expressions at the highest level….
The core UN pillars of human rights, development, peace and security
Keeping Health central to the Drug Policies at the highest level and reflect the same at country levels
INCB, UNODC, WHO, UNAIDS, UN Develoopment Program and other relevant entities in Geneva and New York and Vienna
Interagency participatory action to strengthen the HEALTH component of drug policy
policy reforms can go ahead, guided by evidence and human rights principles but unhindered by legal constraints coming from outdated drug control treaties
Synchronous implementation of WHA 2014 resolution - Strengthening of palliative care within the Health Policy framework
Synergise action plans with the framework of the Sustainable Development Goals
Now that this high level discussion has acknowledged the negative impact of the international drug control system
Did it identify availability of controlled substances for medical purposes as an objective?
Did it include specific agencies and measures to ensure medical availability?
Did it identify prevention of misuse / diversion of controlled medicines as an objective?
Did it include specific measures to prevent such misuse or diversion?
Is there evidence for Interagency cooperation
Developing standards on the use of controlled medicines
for HIV Prevention, Treatment and Care for Injecting Drug Users
Guidelines for opioid substitution therapy
Define the patient who needs a controlled medicine,
Abuse - drug use inconsistent with or unrelated to acceptable medical practice
Support for estimating medical need for controlled substances
Training healthcare workers on appropriate use of opioids
Eliminating excessive restrictions on prescribing and dispensing
Click
The main idea is that when the system’s functioning is optimal and responsibilities are administered efficiently, the DDS will allow for a smooth flow of controlled substances to meet demand, and efficient estimation of annual requirement
Click
while also minimizing the likelihood of diversion occurring.
Errors in the licit system dealt distinctly from illicit system
– drug availability when and where needed, education of professionals, awareness amongst public
Health, Human welfare, Security, Revenue, Law, internal affairs
Accessibility is the degree to which a medicine is obtainable for those who need it at the moment of need with the least possible regulatory, social or psychological barriers.
Availability is the degree to which a medicine is present at distribution points in a defined area for the population living in that area at the moment of need.
The core UN pillars of human rights, development, peace and security
Keeping Health central to the Drug Policies at the highest level and reflect the same at country levels
INCB, UNODC, WHO, UNAIDS, UN Develoopment Program and other relevant entities in Geneva and New York and Vienna
Interagency participatory action to strengthen the HEALTH component of drug policy
policy reforms can go ahead, guided by evidence and human rights principles but unhindered by legal constraints coming from outdated drug control treaties
Synchronous implementation of WHA 2014 resolution - Strengthening of palliative care within the Health Policy framework
Synergise action plans with the framework of the Sustainable Development Goals